Newspaper logo  
 
 
Local News & Opinion

Ref. : Civic Events

Ref. : Arts & Education Events

Ref. : Public Service Notices

Travel
Books, Films, Arts & Education
Letters

Ref. : Letters to the editor

Health Care & Environment

02.05 Take 2 Minutes To Learn Why Obama's $10 Fee On Oil Is So Important

02.05 Flint and the Long Struggle Against Lead Poisoning

02.04 Morocco to switch on first phase of world's largest solar plant

02.04 Zika virus: Rousseff tells all Brazilians to stamp out mosquito breeding grounds

02.04 US electricity industry's use of coal fell to historic low in 2015 as plants closed [if replacement natural gas use isn't hemorraging methane, this is good news]

02.04 Flint water crisis: Michigan officials ignored EPA warnings about toxicity

02.03 Researchers find birds can theorize about the minds of others, even those they cannot see

02.03 Ships' noise is serious problem for killer whales and dolphins, report finds

02.03 We’re drowning in cheap oil – yet still taxpayers prop up this toxic industry

02.03 German scientists to conduct nuclear fusion experiment

02.02 Queensland gives Adani environmental permit for Carmichael coalmine [Australian conservative governments facilitate higher profit energy that kills people]

02.02 Renewables agency stripped of members and run by bureaucrat [Australian conservative governments suppress clean energy]

02.02 Germany leads Europe in offshore wind energy growth

02.02 Oxbridge academics call for 'morally sound' university investments

02.02 British Researcher Gets Permission to Edit Genes of Human Embryos

News Media Matters

02.05 It Takes a Movement to Create Fundamental Change [is change possible given the corporate-fawning orientation of news media]

02.05 Press Versus Liars: Doing Good Journalism in These Trying Times

Daily: FAIR Blog
The Daily Howler

US Politics, Policy & 'Culture'

02.04 New Hampshire town hall: Clinton and Sanders spar over progressive record [Bernie is full-throttle, but Clinton (and Obama) preemptively compromise progressive goals]

02.04 American capitalism has failed us: We’re overworked, underemployed and more powerless than ever before

02.04 Compared to Other Rich Countries, the United States Is Pretty Bad at Fighting Poverty

02.04 Election 2016: Elizabeth Warren Defends Bernie Sanders From Goldman Sachs Criticism

02.04 A tiny home of one's own: black women embrace the small house movement

02.03 Unemployment: The All-but-Certain Fate of Too Many Poor Black BoysUnemployment: The All-but-Certain Fate of Too Many Poor Black Boys

02.03 Clinton Campaign Goes on Tilt as a Result of Dead Heat With Sanders in Iowa

02.03 Jimmy Carter calls US campaign finance ruling 'legalised bribery' [0:50 video]

02.03 Bernie Sanders Knows What Time It Is

02.03 Bernie Sanders Just Changed the Democratic Party

Justice Matters

02.05 How Democracy Died in Flint [ALEC Is at It Again]

02.05 An Idiot’s Guide to Prosecuting Corporate Fraud

02.03 FBI joins probe of Flint, Michigan's lead contaminated water

High Crimes?

02.05 FGM: number of victims found to be 70 million higher than thought

02.05 Israel Continues to Spray Crop-killing Chemicals on Gaza Farmlands; Cancer Fears [genocide]

Economics, Crony Capitalism

02.05 Oil nations face years of pain, says IMF chief Christine Lagarde

02.05 Norway's oil-based wealth fund sells out of more fossil fuel companies

02.04 ICELAND SENTENCES 29TH BANKER TO PRISON, US BANKERS STILL COLLECTING BONUSES

02.03 Worse than the Roaring Twenties: What even Thomas Piketty underestimates about American income inequality

02.03 Why Michael Hudson is the World’s Best Economist

International

02.05 America's Agitator: Donald Trump Is the World's Most Dangerous Man

02.05 EU Border Office Chief on Refugee Crisis: 'We Should Have No Illusions'

02.05 German UN Envoy on Islamic State's Rise: 'We Simply Can't Give Up on Libya'

02.04 Funds for Syria need to be ringfenced for women, civil society groups say

02.04 To Beirut with hope: how the city shaped by refugees makes room for new arrivals

02.04 Join or die The birth and horrifying rise of Boko Haram [A terrorist (and barbaric) response to inequality of wealth & income? Is ISIS the same?]

02.03 Harper’s Index [an incredible amount of “news you can use” on 1 page]

02.03 The West Must Stop Giving Turkey a Free Pass

02.03 ISIL kills 70 in bombing of Shiite Area, Damascus, in bid to derail Talks

02.03 The Breakup of Iraq? Barzani calls for Kurdistan Referendum

02.03 One of Africa’s Biggest Dams Is Falling Apart

We are a non-profit Internet-only newspaper publication founded in 1973. Your donation is essential to our survival.

You can also mail a check to:
Baltimore News Network, Inc.
P.O. Box 42581
Baltimore, MD 21284-2581
Google
This site Web
  Big Pharma Wins Big in Health Care Reform

COMMENTARY:

Big Pharma Wins Big in Health Care Reform

by James Ridgeway
First published in his blog Unsilent Generation yesterday, 22 March 2010
To a large extent, the “debate” over health care was a show debate, an extended round of Washington smoke and mirrors. The administration early on cut its deal with Big Pharma, and pretty much stuck to it throughout the process.

The Republicans look a sour lot this morning, but the pharmaceutical industry, which helps foot the campaign bills of a sizeable chunk of members of both parties, is delighted with the legislation, and with its Democratic friends in the White House and on the Hill.

Members of Congress in both parties generally have lined up behind the insurance and pharmaceutical industries from the get go. So it should come as no surprise that the Democrats, who long ago gave up any pretence of opposing corporate power, found a way to accomodate the pharmaceutical companies on the way to its tepid reform. To a large extent, the “debate” over health care was a show debate, an extended round of Washington smoke and mirrors. The administration early on cut its deal with Big Pharma, and pretty much stuck to it throughout the process.

In fact, the Dems actually made the drugsters look good, celebrating the industry’s generous “concessions” and “discounts” while ensuring that no real threat to Big Pharma’s profits would make their way into the final bill.

The industry’s main goal from the very beginning has been to fend off any government power to negotiate or seriously regulate drug prices–and this they did.

Big Pharma’s second big win was to prevent any measure that would have opened the way for American consumers to buy less expensive drugs abroad, especially from Canada.

At the same time, the supposed give-backs by the drug industry are projected to more than pay for themselves. The much-lauded discounts on brand name drugs for seniors in the Medicare prescription drug program, for example, are good for Big Pharma because they discourage oldsters from switching to generics.

And more insured people simply mean more money coming into the coffers, for Big Pharma as well as for the insurance industry.

Confirmation of the industry analysis came early in the day from the stock market, where drug stocks initially remained level; there certainly was no rush to dump shares, which is what would be expected if the bill actually represented any threat to profits. And by 1 p, EST, CNN Money was reporting a rally in health care stocks.

“I was unable to find anything in there that would cause me to have anxiety if I were a shareholder in a pharmaceutical company,” Ira Loss, a senior health-care analyst at the research firm Washington Analysis, told Dow Jones. According to the ticker story:

Billy Tauzin, who led the industry’s negotiations on health care with lawmakers, said overall drug makers fare well. “While we’re not totally happy,” Tauzin began, “we generally feel like it tracks with our principles.”

Sanofi-Aventis SA (SNY) Chief Executive Christopher Viehbacher said in an interview that the impact of the legislation will be neutral to slightly negative “but better for the industry than if healthcare reform didn’t pass.”

Tauzin, head of the Pharmaceutical Research and Manufacturers of America or PhRMA, and Viehbacher said getting protection for brand-name biologics is among the important provisions for the industry. Drug makers pushed hard to get 12 years of exclusive market protection while the White House and some lawmakers wanted to lower the protection to seven years.

Despite fees and rebates imposed by the legislation, “analysts say drug makers will end up recouping those costs through new customers: The bill would provide insurance coverage to an additional 32 million Americans.” The Dow Jones story continues:

Chalk up another good round for Pharma and Biotech in health care reform,” began a note to clients Friday from Concept Capital, a research firm.Ken Tsuboi, co-manager of the Allianz RCM Wellness Fund, sees the impact of bill, and its $90 billion in concessions over 10 years, as relatively minor in an industry that has annual global sales of about $750 billion, with about $300 billion in the U.S., and margins close to 30%.”I think that it is actually a pretty good deal for Pharma,” Tsuboi said.

The GOP, which purports to be the party of big business, ought to be applauding at least these portions of the health care reform—and perhaps when the cameras go away, some of them will quit bitching and count their blessings. As for the obnoxious Tea Party gang, if they start threatening the real power in this country, which is vested in corporations, they may well find themselves whipped and isolated.


Born in 1936, James Ridgeway has been reporting on politics for more than 45 years. He is currently Senior Washington Correspondent for Mother Jones, and recently wrote a blog on the 2008 presidential election for the Guardian online. He previously served as Washington Correspondent for the Village Voice; wrote for Ramparts and The New Republic; and founded and edited two independent newsletters, Hard Times and The Elements.

Ridgeway is the author of 16 books, including The Five Unanswered Questions About 9/11, It’s All for Sale: The Control of Global Resources, and Blood in the Face: The Ku Klux Klan, Aryan Nations, Nazi Skinheads, and the Rise of a New White Culture. He co-directed a companion film to Blood in the Face and a second documentary film, Feed, and has co-produced web videos for GuardianFilms.

Additional information and samples of James Ridgeway’s work can be found at JamesRidgeway.net and at his newest web site, Solitary Watch.

This article is republished in the Baltimore Chronicle with permission of the author.



Copyright © 2010 The Baltimore News Network. All rights reserved.

Republication or redistribution of Baltimore Chronicle content is expressly prohibited without their prior written consent.

Baltimore News Network, Inc., sponsor of this web site, is a nonprofit organization and does not make political endorsements. The opinions expressed in stories posted on this web site are the authors' own.

This story was published on March 23, 2010.
 



Public Service Ads:
Verifiable Voting in Maryland